Increasing instances of substandard, falsified and counterfeit medical products continue to pose a major challenge to the global healthcare system which is already suffering from the dire impact of COVID-19. To address this issue, ASPA and Messe Frankfurt India will unite leading experts from
MoreEA Pharma Co., Ltd. and its parent company Eisai Co., Ltd. announced that Japan’s Ministry of Health, Labour and Welfare
MoreNanoViricides, Inc. (NYSE American: NNVC) (the “Company”) a leader in the development of highly effective antiviral therapies based on a
MoreFollowing the announcement by Messe Duesseldorf that interpack 2020, which was scheduled for May, will be postponed to next year,
MoreThe €6.3 million, four-year new joint research project aims to develop microbiome-based solutions to establish a healthy microbiome in early
MoreAward-winning global leader in digital patient recruitment GeoMap Clinical by TrialWire announced today new tools added to the GeoMap geo-targeting
MoreDuPont Nutrition & Biosciences (DuPont) today announced a collaboration with the MRM Health NV (MRM Health), a biopharmaceutical company, focused
MoreImproving adherence to medication via smarter, patient-centric pharmaceutical packaging and extracting further value from existing medicines and delivery devices are
MoreConvenience and large inventory remain key points of attraction for consumers, which makes hospital pharmacies the primary distribution channel in
MoreAIM ImmunoTech Inc. (NYSE American:AIM) announced the filing of three provisional patent applications related to its drug candidate Ampligen in
MorePBSC have led the way, providing high quality products and services to pharmaceutical, medical research, high containment and hospital research
More